27, Jun 2024
QPS Announces New Laboratory Services for Clinical Trials and Cell Therapy Development
Newark, Del., United States
QPS, a leading global contract research organization (CRO), is pleased to announce new laboratory services capabilities. The central laboratory, leukopak cell therapy facility, and enhanced PBMC capabilities will complement existing bioanalysis, translational medicine and peripheral blood mononuclear cell (PMBC) laboratories and extend the current QPS full-service global CRO offerings.
QPS Missouri, a division of QPS Holdings, LLC, a global Contract Research Organization. QPS Missouri conducts Phase I-IV clinical trials and houses central lab, safety lab, PBMC and cell production services in Springfield, Missouri. (Photo: Business Wire)
QPS Missouri, a division of QPS Holdings, LLC, a global Contract Research Organization. QPS Missouri conducts Phase I-IV clinical trials and houses central lab, safety lab, PBMC and cell production services in Springfield, Missouri. (Photo: Business Wire)
QPS now offers clinical trial sample analysis services and leukopak cell therapy products from its newly expanded clinical trials unit conveniently located in Springfield, Missouri. In addition, QPS has also expanded PBMC service offerings from its Miami, Florida location into its Springfield, Missouri laboratories. The new facilities are housed with an existing clinical (safety) laboratory, a modern self-contained pharmacy, and dedicated space to build and ship clinical trial kits.
The modern central laboratory for sample analysis complements the existing on-site safety laboratory, equipped with the most up-to-date technologies for chemistry, urinalysis, serology, coagulation, and hematology testing. These capabilities, designed to monitor subject safety during ongoing clinical trials, will remain as core services for QPS in-house clinical trials.
The new leukopak products collection and processing facility is designed to meet the exponential growing demand for blood products to support cell therapy research and QPS is ideally placed to provide this service. QPS Missouri has a database of over 35,000 potential study participants, who can be contacted as potential blood donors for leukopak products.
“There is significant unmet demand in this rapidly growing area of cell therapy products, which represents a tremendous opportunity for QPS. Over 3,000 cell and gene therapy programs are currently in progress representing a 20% increase over the past five years. These programs require leukopak products to move forward, and as a result this market is forecasted to grow by a CAGR of more than 8% over the next six years,” said Benjamin Chien, Chairman, President and CEO of QPS.
The enhanced PBMC services include a new PBMC processing lab at the Springfield location, complementing the existing lab at QPS Miami in Miami, Florida. This new lab will support a current unmet need for PBMC processing in the midwestern USA. PBMC sample analysis is a time-consuming process, typically required in vaccine trials, and it is best done in a lab adjacent to the clinical trial unit. QPS is uniquely positioned to offer this service.
“These new facilities, services and products extend our full service CRO capabilities, putting QPS in a position to offer clients comprehensive clinical research services in one location. The central lab, PBMC lab, and the leukopack facility complement and enhance our current 240 bed clinical trials unit, safety laboratory, modern self-contained pharmacy, and clinical trial kit production facility,” said Brendon Bourg, Vice President, Early Phase Clinical and Head of Administration at QPS Missouri.
- 0
- By Rabindra
27, Jun 2024
More Home Health Cuts in 2025 Further Undermine Patient Access to Care
Washington, DC, June 27, 2024 — The Partnership for Quality Home Healthcare today warned that the permanent -4.067 percent payment cut to home health services proposed by the Centers for Medicare & Medicaid Services (CMS) will further undermine the delivery of high-quality home healthcare services to millions of older Americans. Despite several years of significant Medicare home health payment cuts and reliable data demonstrating a troubling decline in the number of home health patients and patient visits, CMS has again proposed additional permanent cuts to home health in 2025.
“For the third consecutive year, CMS has proposed cuts that make it significantly harder for home health providers to meet the care demands for an increasingly complex and aging patient population,” said Joanne Cunningham, CEO of the Partnership. “The status quo of continuous cuts is unsustainable: Medicare’s continued application of permanent cuts to home health further undermines a community that is facing historic labor costs and workforce shortages. We fear that CMS’s proposed actions for 2025 will have unintended consequences on older Americans who want to receive care at home.”
The Home Health Prospective Payment System (“HHPPS”) Proposed Rule for Calendar Year (CY) 2025 includes the full current remaining permanent adjustment of -4.067 percent to the CY 2025 home health base payment rate. The overall economic impact related to the changes in payments under the HH PPS for CY 2025 is estimated to be -$280 million (-1.7 percent).
Since adopting a new payment model for the Medicare Home Health Program, annual cuts to home health have diminished the provider community’s ability to maintain an adequate workforce to meet patient need, transfer patients home following hospitalization, and ensure home health services are accessible to Medicare beneficiaries across the country. To summarize the impact of Medicare’s home health cuts to date:
· Starting in 2020, CMS’s cuts are producing an estimated total cut of $20 billion from Medicare home health payments through 2029.
· These deep and destabilizing cuts have already resulted in agency closures, service area reductions, and a reduction in home health services.
· Patient access to home health is already declining, with 500,000 fewer patients receiving care through the Medicare home health program this year compared to 2019—despite increasing demand for care.
· The costs to hire and deploy clinicians to deliver care in the home are increasing (outpacing CMS’s market basket updates), as are related costs such as fuel and medical supplies.
· Home health agencies struggle to recruit, retain, and sustain a steady workforce to meet patient demand, as healthcare workers are in short supply.
In a February 2024 letter to CMS, the Partnership and the National Association for Home Care & Hospice wrote, “Our members continue to report closures, declining capacity, and immense challenges as they struggle to hire nurses and address other workforce constraints… In addition, while inflation has cooled somewhat from its peak, costs remain high, and CMS’ annual payment updates have not kept pace with inflation… The financial pressures created by the combination of these factors make it extremely challenging to provide high-quality services and support continued access in broader services areas, including rural locations.”
CMS has again used the market basket increase (+2.5%) to mask the impact of the permanent reimbursement rate cut (-4.067%), an approach that is unsustainable and inconsistent with the purpose of an update to account for increases in the costs of care.
In addition to the permanent payment cut, CMS also calculated temporary adjustments of $4.55 billion to be recouped in future years. CMS recognizes in the new proposed rule that “implementing both the permanent and temporary adjustments in the same year may adversely affect HHAs.”
“We are very disappointed that CMS did not use its authority to suspend further reductions to home health payments in CY 2025, despite our repeated requests and data demonstrating decreased access to home health services,” added Cunningham. “The role of Congress in alleviating the burden of these cuts is now increasingly important, and we will be calling on our champions in Congress to finish the job on legislation to block these harmful cuts this year.”
A bipartisan group of lawmakers has introduced legislation to block further cuts to the Medicare home health benefit. The Preserving Access to Home Health Act (S. 2137/H.R. 5159) – introduced by Senators Debbie Stabenow (D-MI) and Susan Collins (R-ME) and Representatives Terri Sewell (D-AL) and Adrian Smith (R-NE) – prevents CMS from implementing cuts to the Medicare Home Health Program in 2025 and in future years.
27, Jun 2024
Sarvodaya Hospital Restores Hearing for India’s Second Youngest Child with Cochlear Implant
Faridabad, 27th June 2024 – Furthering their commitment to serving the community through affordable and compassionate care and top-class medical facilities, Sarvodaya Hospital, Faridabad achieved a ground-breaking medical milestone by treating a 6-month-old baby for ‘Congenital Hearing Loss’. This marks India’s 2nd youngest case of a successful Cochlear implant.
The child’s parents were both deaf and mute, prompting the family to undertake an early screening for the baby. Certain tests were conducted such as Brainstem Evoked Response Audiometry (BERA) and Auditory Brainstem Response (ABR) which are essential diagnostic tools used to evaluate hearing loss, especially in infants and young children. The tests revealed that the baby was suffering from ‘Congenital Hearing Loss’ in both ears. A condition in which a child is born without the ability to hear is known as congenital deafness. This type of hearing loss occurs either due to abnormal development of the auditory system during fetal development or as a result of genetic inheritance from the parents. Following this diagnosis, the baby underwent Cochlear implant surgery and was able to hear successfully.
Cochlear implants are electronic devices that help people with severe hearing loss hear sounds. They work by bypassing damaged parts of the ear and directly stimulating the hearing nerve. The device has two parts: Internal device is surgically placed inside the ear, and the external device comprises of speech processor, a transmitting coil, and a microphone. The external device receives the sound and converts them into digital signals, these signals are transferred to the internal device, which stimulates the auditory nerve. Together, they help send sound signals to the brain, allowing the person to hear.
Commenting on the case, Dr Ravi Bhatia, Director- ENT and Cochlear Implants, Sarvodaya Hospital, Faridabad, said, “6-8 out of every 1000 children born in India are detected to have congenital hearing loss, although, a large number of newborns are not screened for hearing loss at birth, hence, the actual incidence is expected to be much higher in the community. Globally, the success rate of cochlear implant surgeries in both children and adults exceeds 98%. While cochlear implants can be performed at any age, the timing of hearing loss onset significantly affects outcomes. Early identification and intervention are particularly crucial for children with severe to profound hearing loss, yielding immediate and positive responses. This was a critical case in which both parents of the baby were deaf and mute, which led the grandparents to get the baby screened. For children, cochlear implants can be life-changing, allowing them to engage with the auditory world, develop typical speech, language milestones, and compete with their peers who have normal hearing. Cochlear implant surgery has proven to be highly successful for both children and adults.”
Mr. Raja Suman, Chief Audiologist, Centre of ENT and Cochlear Implant, Sarvodaya Hospital, Faridabad, further added, “The child underwent continuous monitoring to ensure optimal progress. Our team of professionals, including audiologists, auditory-verbal therapists, and speech-language pathologists, closely tracked the child’s auditory development, speech, and language. This comprehensive approach aimed to provide tailored support and guidance throughout the rehabilitation process, enabling the child to hear successfully.”
The case study exemplifies Sarvodaya Healthcare’s commitment to providing advanced cochlear implant surgeries on young children with optimum care and post-surgery rehabilitation and therapy, ensuring compassion, cutting–edge technology, accessibility, affordability, patient safety, and quality in all healthcare services offered. Sarvodaya Hospital has successfully performed over 300 cochlear implants, enhancing the hearing capabilities and quality of life for many patients.
27, Jun 2024
Florida Association of ACOs Welcomes Bold as New Member
Jacksonville, FL, June 27, 2024 — The Florida Association of Accountable Care Organizations (FLAACOS) proudly announces the addition of Bold to its growing network of partners. Bold, a trailblazer in healthy aging, specializes in evidence-based exercise programs designed to prevent falls, manage chronic conditions, and reduce joint pain among older adults. This collaboration is particularly significant in Florida, a state with the largest senior population in the United States, where Bold’s clinical exercise programs are poised to make a profound impact.
Falls are a leading cause of hospitalizations and injuries among seniors. In 2020 alone, over 1 million Floridians aged 65 and older reported a fall. Bold’s rigorous balance and strength training programs offer a preventative solution that can significantly reduce these incidents. According to CDC data, more than one in four seniors experiences a fall each year, resulting in over $50 billion in medical expenses.
Moreover, physical inactivity is a major contributor to chronic conditions, which are among the most costly health issues for older adults. Studies indicate that the cost of managing these conditions can exceed $1,000 annually per person. Despite the clear benefits, less than 15% of seniors in the U.S. meet the recommended physical activity guidelines. Bold’s innovative approach aims to bridge this gap by making exercise more accessible and tailored to individual needs.
Amanda Rees, CEO and Co-Founder of Bold, emphasizes the transformative potential of this partnership: “By collaborating with ACOs, Bold can help reduce healthcare costs while significantly enhancing the physical and mental well-being of members. Our online, on-demand solution addresses common barriers to exercise, such as transportation challenges, joint pain, fear of injury, and busy schedules, by offering personalized exercise plans that seniors can follow from the comfort of their homes.”
Notably, Bold’s programs not only contribute to cost savings but also boost member satisfaction and retention. Surveys reveal that 8 in 10 participants are more likely to remain with their healthcare plan or provider due to the positive impact of Bold’s offerings.
Nicole Bradberry, CEO of FLAACOS, expresses her enthusiasm for the new partnership: “We are thrilled to welcome Bold as a business partner. Their proven ability to deliver cost-effective and high-quality health solutions is a tremendous asset to our member ACOs. Bold’s approach provides quantifiable benefits in both financial savings and improved health outcomes.”
As FLAACOS continues to serve the healthcare needs of Floridians, the inclusion of Bold represents a significant step forward in promoting a longer, healthier, and more active life for the state’s senior population.
26, Jun 2024
Mobile Wellness Care Expanding Revolutionary Health Services Beyond Arizona and Utah
Phoenix, AZ, June 26, 2024 –Mobile Wellness Care, a trailblazer in providing on-demand health services directly to clients’ homes, today announced its ambitious expansion beyond its successful operations in Arizona and Utah. The company, which specializes in chiropractic, acupuncture, and massage therapy, is setting a new benchmark for accessible and personalized healthcare across the United States.
Since its inception, Mobile Wellness Care has revolutionized how clients receive health treatments by eliminating the need to travel to traditional clinics. The expansion aims to address the growing demand for convenient healthcare services that cater to the busy schedules of modern consumers. With a focus on high-quality, personalized care, Mobile Wellness Care ensures that professional wellness services such as chiropractic adjustments, therapeutic massages, and acupuncture treatments are just a few clicks away.
Dr. Clinton Huston, chiropractor and co-founder of Mobile Wellness Care, expressed enthusiasm about the expansion: “We started Mobile Wellness Care with a vision to transform the healthcare delivery model. Seeing our vision come to life and as we begin to expand beyond Arizona and Utah is incredibly rewarding. Our service not only provides convenience but also alleviates the stress associated with managing health. As we grow, we’re excited to introduce more people to the benefits of mobile chiropractic, acupuncture, and massage therapy, ensuring they have access to the care they need, right in the comfort of their own homes or any other location of their choice.”
Mobile Wellness Care is committed to maintaining the highest standards of care as it grows. Each practitioner is extensively vetted and trained to deliver exceptional service, ensuring that every treatment session is safe, relaxing, and beneficial. The services are designed to fit seamlessly into clients’ lives, promoting better health without the inconvenience of traditional healthcare settings.
Ericka Huston, co-founder, added, “Our mission at Mobile Wellness Care has always been to make wellness easy and accessible for everyone. As we expand, our focus remains on empowering clients by providing them with more control over their health and well-being. We believe that everyone deserves to experience the healing benefits of chiropractic care, acupuncture, and massage therapy without the hassle of waiting rooms or unnecessary stress.”
The expansion plan includes not only broadening the geographic footprint but also enhancing the range of services offered. Mobile Wellness Care is developing new wellness packages and group offerings, making it an ideal choice for families, businesses looking to support employee health, and communities seeking group health solutions.
With the health and wellness industry evolving rapidly, Mobile Wellness Care’s innovative approach addresses the crucial need for flexibility, affordability and personalization in healthcare. The expansion is set to roll out over the next several months, with detailed information on new service areas to be made available on the company’s website and through direct communication with existing and prospective clients.
25, Jun 2024
Dr Annurag Batra Chairman BW is Being Elected as a Member of the International Academy of Television Arts & Sciences
25th June 2024 Mumbai, Maharashtra, India Dr. Annurag Batra is respected and revered in the media and television industry through his contribution of setting up exchange4media and institutionalizing exchange4media, and creating a new and pioneering platform for media, television and related domains in digital and building a pioneering & impact making organization in a 360 degree.
Dr Annurag Batra has serendipitously created a new sector and an industry that is respected and emulated by all others in the domain.
Dr Annurag Batra is a Serial Entrepreneur, an Author, an Angel Investor, a TV show host, a nationalist and a full-time dreamer who believes anything you Believe in deeply manifests itself in reality. Dr Batra is the Founder and Editor in Chief of exchange4media group (www.exchange4media), managing several big media brands that he has created from scratch under its aegis. Dr Batra is the Chairman and Editor-in-Chief of BW Businessworld Media Group (www.businessworld.in) which is in its 44th year and amongst the topmost respected business media platforms which are 360 degree and media neutral. Dr Batra has been busy pivoting and turning around BW Businessworld a company he acquired in late 2013 and in the last 9 plus years BW Businessworld has pivoted to becoming a content tech media conglomerate and is making an impact in India with its futuristic approach. Dr Batra I also served as a Member of the Board of Governors of the prestigious Management Development Institute, Gurgaon (www.mdi.ac.in) his own Alma Matter and Dr Batra is the first PGPM (MDI s flagship program) graduate from MDI Gurgaon to be on its Board of Governors for last 3 years and half years from 12th Jan 2020 to June 2023. Dr Batra believes what Confucius said, “If you make your hobby your profession you don’t have to work.” DrBatra believes deeply in spirituality, Indian Vedas, and the power of ideas and dreams to achieve anything we believe we can. Dr Batra is a die-hard optimist and believes sharing creates happiness.
Dr Annurag Batra has a unique position in the Indian media industry. While he is a media mogul in his own right having founded the exchange4media group 24 plus years back which is the homepage of everyone in the media industry as well as Dr Batra acquired BW Businessworld group 9 years back and has grown it multi-folds as a 360-degree media platform.
As the founder of the exchange4media group over the last 24 years plus, Dr Batra has interacted deeply with leading media owners, editors, journalists, and new-age media professionals. Dr Batra in the course of building exchange4media.com, samachar4media.com, Impact and Pitch, and the 75 plus experiential large scale IP s of exchange4media, Dr Batra is in touch with the depth and width of the media industry across India. Dr Batra has written extensively on media and is an accepted authority on media, television and new media. His book out likely in 2025 and titled “Media Moguls of India”. Dr Batra truly brings the network effect to play through his deep personal relationships. Dr Batra has a deep and personal approach to all issues and understands one has to do the right thing in the right manner for the right reason for the right impact. With his being on the ground in his dual roles as exchange4media and BW Businessworld Dr Batra understands what media wants and how media works. Dr Batra believes in the three C’s for media impact, Content, Connect, and Context.
Dr Annurag Batra is also setting up his initiatives in UAE and MENA and you will see the media companies and media tech companies that have been mentored and invested by him also entering UAE and MENA.
Dr Annurag Batra has also angel-invested in many futuristic media tech startups that are impacting the Indian digital media and media tech.
25, Jun 2024
Homi Lab Launches Dr. Kalam Future Lab to Nurture Future Innovators
25th June 2024 New Delhi, Delhi, India Homi Lab launched its inaugural Dr. Kalam Future Lab at SMCP Sanskar Vidya Bhavan, an educational facility designed to teach children about futurism and prepare them for future careers at Bharuch, Gujarat. The lab features a combination of a curated syllabus, expert trainers, virtual reality, immersive content, and a humanoid.
The inauguration, organized by the Sanskar Bharati Trust, saw Bharuch District Collector Shri Tushar Sumera as the Chief Guest and Homi Lab Founder Shri Srijan Pal Singh as the Guest of Honour. The event began with the traditional lighting of the lamp by these guests and other trustees.
The inauguration showcased a prayer song, a welcome dance, and a musical skit titled “Sky is the Limit,” which portrayed the journey of ISRO. Mrs. Shailja Singh, Principal of SMCP Sanskar Vidya Bhavan, underscored Homi Lab’s role in encouraging scientific curiosity and innovation among students.
Shri Sumera emphasized the importance of scientific inquiry and critical thinking. Shri Singh discussed Homi Lab’s goal to foster future thinkers and innovators.
“Kalam Future Lab is a valuable addition to Bharuch. With the efforts of SMCP Sanskar Vidya Bhavan and support from Sanskar Bharati Trust, I am confident that this will provide opportunities to students at Bharuch to learn and aspire to reach even greater heights. With changing times, it is essential that we follow the wisdom of Dr. Kalam and have the courage to dream big. It is our responsibility to make learning an optimist endeavour and contribute towards nation-building,” added Tushar Sumera, IAS, DM, Bharuch.
“I am happy to see the implementation of the first Dr. Kalam Future Lab in Gujarat happening in Bharuch. Dr. Kalam believed that India would be a developed nation only when the highest quality education with a value system is available to all – without any economic and social discrimination. Today, Sanskaar Bharti School along with Homi Lab is implementing a pioneer learning centre for teaching children about futurism – where they will imagine, design and prepare for careers and opportunities which will flourish a decade ahead. Never before such an educational system, a combined system of curated syllabus, expert trainers, virtual reality, immersive content and even a humanoid, has been deployed for school children across the world – and such long-term thinking is a testimony of the new India,” said Shri Srijan Pal Singh.
The event concluded with the unveiling of the Future Zone, powered by Homi Lab in collaboration with the Kalam Centre, and an inspiring presentation on the Future Vision by Campus Director Mr. Kulwant Marwal, indicating Homi Lab’s trajectory in shaping future generations.
25, Jun 2024
New Memoir Sheds Light on Traumatic Brain Injury Recovery with Humor and Insight
Studio City, CA, June 25, 2024 — Early Reviews are In:“An engaging, real, and often funny account about the difficult road to
recovery that is sure to help TBI survivors like myself.” -Cristin Zeisler, JD,OTD, CEO, Cognition Center
In an inspiring literary memoir debut, The Best of the Worst: My True Story of Surviving and Thriving After a Traumatic Brain Injury, published by Rainmaker Publishing, Emily Silver Owen offers a profound glimpse into the life-altering journey of getting her life back after suffering a Traumatic Brain Injury (TBI). Released on June 21, 2024, Owen’s narrative captures the essence of resilience, hope, and the undying human spirit in the face of adversity.
Struck by a drunk driver in a life-changing moment on September 7, 2019, Emily’s world was turned upside down. Walking her dog just minutes after taking a photo outside a bar, she became another statistic in the ever-growing number of TBI cases worldwide. However, refusing to be defined by her injury, Emily’s memoir transcends the story of the accident to spotlight the challenging yet rewarding road to recovery. Through her candid recounting, readers are invited into the day-to-day battles and triumphs that mark the TBI recovery journey.
The Best of the Worst opens with a powerful analogy about living with TBI, likening the experience to a series of frustrating mishaps that encapsulate the disconnect between desire and ability. Yet, it is through this lens of struggle that Emily’s humor, strength, and determination shine brightest. Her narrative is not just her own but serves as a source of inspiration for others navigating the aftermath of a TBI.
TBI affects millions annually, with the Centers for Disease Control and Prevention (CDC) reporting that in the United States alone, there are approximately 2.8 million TBI-related emergency department visits, hospitalizations, and deaths each year. Despite its prevalence, TBI remains a misunderstood and often invisible injury, underscoring the significance of firsthand accounts like Emily’s in raising awareness and understanding.
Endorsed by healthcare professionals and survivors alike, The Best of the Worst is hailed as a crucial contribution to the literature on brain injury. Victoria Katomski, Director of Rehabilitation at the Centre for Neuro Skills and a leading speech and cognitive therapist specializing in TBI recovery, praises the book saying, “Em is a testament to what is possible to accomplish in life after brain injury.”
Emily’s story is more than a memoir; “I will spend the rest of my life trying to right the wrong I experienced,” she declared. Her mission transcends personal healing, aiming to influence a global awareness of TBI and the importance of mindfulness in everyday actions.
24, Jun 2024
Tomoko Uno Opens new QHHT Healing Center in Tucson, AZ
Tucson, AZ, June 24, 2024 –Tomoko Uno opened Healing Within, a new QHHT healing center conveniently located on Fort Lowell Rd.
Originally from Japan, Tomoko is a lifelong practitioner of the healing arts, having studied an ancient form of Japanese Shamanism with the Kannagi and Miko (Shinto mystics and healers). Today, Tomoko is a certified QHHT practitioner committed to helping individuals unlock their full potential and achieve holistic wellness. She says, “I’m thrilled to bring QHHT to Tucson and look forward to contributing to the vibrant local healing community. This is a dream come true for me!”
Quantum Healing Hypnosis Technique (QHHT) is a unique and powerful form of hypnosis developed by Dolores Cannon. This technique facilitates access to the subconscious mind, where profound healing and deep insights can be attained. QHHT goes beyond traditional hypnotherapy by exploring past lives and tapping into a higher consciousness that hold answers to life’s most pressing questions.
Fluent in both English and Japanese, Tomoko bridges cultural and linguistic gaps, making her services accessible to the diverse range of clients living in the Tucson area. Her unique background and personal experiences enrich her practice, allowing her to connect with clients on a deep and empathetic level.
As a newcomer to Tucson, Tomoko’s goal is to create a supportive and nurturing environment where clients can explore their inner world and achieve wellness. Tomoko believes in the innate wisdom and healing potential within each person and is dedicated to assisting clients on their journey toward wholeness and empowerment.
Whether working with English-speaking clients or those who prefer Japanese, Tomoko offers private, in-office sessions that last approximately four hours and can be scheduled online at your convenience. The waiting list is currently around 3-4 weeks.
Once per month on weekends, Tomoko can also be found at the Tucson Psychic and Healing Fair located at the Crystal Event Center, 610 W Prince Rd, Tucson, AZ 85705. This is a monthly event with some of the finest healers and readers in Southern Arizona.
24, Jun 2024
The Successful Partnership Between MAIA Biotechnology and Cromos Pharma
Portland, OR, June 24, 2024 — MAIA Biotechnology, a leader in targeted therapy and immuno-oncology, has partnered with Cromos Pharma, a US-based international clinical research organization, to continue making significant strides in cancer treatment research. This collaboration focuses on the development and commercialization of THIO, a novel telomere-targeting agent aimed at treating non-small cell lung cancer (NSCLC) in patients with telomerase-positive cancer cells. This partnership underscores a joint commitment to revolutionizing cancer therapy through innovative approaches.
At the recent ASCO 2024 conference, MAIA unveiled compelling interim clinical data on THIO, capturing significant attention and excitement for its potential to revolutionize cancer therapy. The latest clinical data demonstrates promising disease control, response rates, and benefits post-therapy for THIO.
Key Findings of the Ongoing Phase 2 THIO-101 Clinical Trial:
• Disease Control Rate (DCR): 85% with THIO and Libtayo in NSCLC patients who failed two or more standard-of-care therapy regimens.
• Primary Objectives: Safety and tolerability of THIO, and clinical efficacy measured by overall response rate (ORR).
THIO, combined with Libtayo, shows significant disease control in advanced NSCLC patients, indicating a promising new treatment approach for those who have exhausted other options.
The success at the ASCO 2024 conference stems from a strong collaboration between MAIA Biotechnology and Cromos Pharma. Playing a crucial role in the THIO-101 trial, Cromos Pharma excelled particularly in patient recruitment, successfully enrolling 85% of participants from key European countries—outperforming other regions involved in the trial. They also managed trial sites and secured the necessary regulatory approvals efficiently across these countries, ensuring a smooth and effective progression of the trial.
Cromos Pharma is proud to partner with MAIA in advancing innovative cancer therapies. The company values its role in this noble endeavor and is committed to supporting MAIA’s mission to improve and extend the lives of cancer patients through ongoing collaboration.
About MAIA Biotechnology, Inc.
MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Its lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells.
